Nordson Corporation NDSN reported better-than-expected results for the second quarter of fiscal 2020 (ended Apr 30, 2020). Both earnings and sales surpassed the consensus estimate by 23.44% and 4.13% respectively.
Adjusted earnings, excluding one-time charges and gains, in the reported quarter were $1.58 per share, surpassing the Zacks Consensus Estimate of $1.28. Moreover, the bottom line increased 2.6% from the year-ago figure of $1.54 as lower costs and expenses made up for the decline in sales.
In the reported quarter, Nordson’s net sales were $529.5 million, down 3.9% year over year. The top line suffered from a 2.5% decline in organic volumes and 1.4% adverse impact of unfavorable movements in foreign currencies, partially offset by gain from acquisitions. Further, the top line surpassed the Zacks Consensus Estimate of $508 million.
At the end of the reported quarter, backlog was $456 million, up 6% year over year.
On a regional basis, revenues from the United States dropped 0.9% year over year to $188.9 million. Revenues generated from operations in Japan grew 5.1% to $31.6 million, while that from the Asia-Pacific region declined 0.7% to $136.2 million. Revenues generated in Europe fell 9% to $136.1 million and that in the Americas declined 16% to $36.7 million.
The company realigned its business segments in March 2020 and now reports under Industrial Precision Solutions and Advanced Technology Solutions. Notably, the Industrial Precision Solutions segment includes the results of the company’s previous two segments — Industrial Coating Systems and Adhesive Dispensing Systems. A brief discussion on the segmental performance in the quarter under review is provided below:
The Industrial Precision Solutions segment’s revenues totaled $282.3 million, down 6.5% year over year. The segment suffered from a 4.5% fall in volumes and 2% adverse impact of foreign currency translation.
Advanced Technology Solutions’ revenues were $247.204 million, down 0.8% year over year. The fall was due to a 0.6% adverse impact of foreign currency movements and 0.2% decline in volumes.
In the quarter under review, Nordson’s cost of sales declined 3.9% year over year to $239.9 million. It represented 45.3% of net sales in the quarter. Selling and administrative expenses contracted 4.7% year over year to $164.6 million. It represented 31.1% of net sales in the reported quarter versus 31.3% in the year-ago quarter.
Adjusted earnings before interest, tax, depreciation and amortization (EBITDA) in the quarter under review were $151.6 million, down 2.8% year over year.
Operating profits declined 3% year over year to $125 million while the margin came in at 23.6% versus 23.4% in the year-ago quarter.
Balance Sheet & Cash Flow
Exiting the fiscal second quarter, Nordson’s cash and marketable securities were $306.3 million, up from $115.1 million at the end of the previous quarter. The company’s long-term debt increased 15.2% sequentially to $1,237.2 million.
In first-half fiscal 2020, the company generated net cash of $218.2 million from operating activities, reflecting a year-over-year increase of 34.8%. Capital spent on the addition of property, plant and equipment fell 2.9% to $25.8 million. Free cash flow was $192.4 million, reflecting an increase of 41.2% from the year-ago period.
During the reported quarter, the company used approximately $38 million to buy back 300,000 shares and pay dividends amounting to $22 million.
For fiscal 2020 (ending October 2020), Nordson withdrew its projections due to uncertainties emanating from the coronavirus outbreak. Meanwhile, the company mentioned that a well-diversified business structure and a healthy balance sheet are major positives.
Nordson Corporation Price, Consensus and EPS Surprise
Nordson Corporation price-consensus-eps-surprise-chart | Nordson Corporation Quote
Zacks Rank and Stocks to Consider
With a market capitalization of $10 billion, Nordson currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Zacks Industrial Products sector are Silgan Holdings Inc. SLGN, II-VI Incorporated IIVI and Broadwind Energy, Inc. BWEN. While both Silgan and II-VI currently sport a Zacks Rank #1 (Strong Buy), Broadwind Energy carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
In the past 30 days, earnings estimates for Silgan and II-VI have improved for the current year, while the same have been unchanged for Broadwind Energy. Further, earnings surprise for the last reported quarter was 16.33% for Silgan Holdings, 213.33% for II-VI and 200% for Broadwind Energy.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Silgan Holdings Inc. (SLGN) : Free Stock Analysis Report
IIVI Incorporated (IIVI) : Free Stock Analysis Report
Nordson Corporation (NDSN) : Free Stock Analysis Report
Broadwind Energy, Inc. (BWEN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research